Showing results (1581-1590 of 9,125) with videos related to
Sort By:
Pageof 913
Cancer Medicine|November 8, 2025
Cervical Adenocarcinoma: What's Special About the Long-Term Reproductive and Oncological Outcomes of Fertility-Sparing Radical Trachelectomy in It?Jingwen Gan, Dongyan Cao, Huimei Zhou, et al.Cancer Medicine|October 3, 2025
Implementation of the Hospitalist System and In-Hospital Mortality Among Patients With Cancer: Using the National Health Insurance Cohort DataYun Seo Jang, Il Yun, Yu Shin Park, et al.Cancer Medicine|October 1, 2025
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE StudyAmanda Nizam, Charles B Nguyen, Jinju Li, et al.Cancer Medicine|September 29, 2025
Development and Validation of a Predictive Model for Occult Liver Metastasis in Pancreatic Ductal Adenocarcinoma Using Subjective Imaging and Clinical DataJia-Bei Liu, Qian-Biao Gu, Jia He, et al.Cancer Medicine|September 29, 2025
Pain and Cognitive Concerns Among Breast Cancer Survivors: The Mediating Role of Substance Use CopingYesol Yang, Alai Tan, Leorey N Saligan, et al.Cancer Medicine|May 31, 2020
Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3-day aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 studyJianhua Chang, Gongyan Chen, Dong Wang, et al.Cancer Medicine|May 14, 2020
Improved outcomes after radiotherapy for prostate cancer: Anticoagulation, antiplatelet therapy, and platelet count as key factors in disease progressionStanley I Gutiontov, Kevin S Choe, Jonathan L Miller, et al.Cancer Medicine|June 20, 2020
Long noncoding RNA FOXD2-AS1 aggravates hepatocellular carcinoma tumorigenesis by regulating the miR-206/MAP3K1 axisWei Hu, Hui Feng, Xiaoyu Xu, et al.Cancer Medicine|September 18, 2021
Development and validation of a PBRM1-associated immune prognostic model for clear cell renal cell carcinomaJiayi Chen, Chunlin Yao, Nan Qiao, et al.Cancer Medicine|August 1, 2022
The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence scoreZheng-Jun Yang, Yu-Xiao Liu, Yue Huang, et al.Pageof 913